Euclidean-Capital

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
11
Total Value
266117115
Accession Number
0001012975-25-000241
Form Type
13F-HR
Manager Name
Euclidean-Capital
Data Enrichment
82% identified
9 identified2 unidentified

Holdings

11 positions • $266.1M total value
Manager:
Search and click to pin securities to the top
46429B598
Shares:2.4M
Value:$124.8M
% of Portfolio:46.9% ($124.8M/$266.1M)
922042775
Shares:2.0M
Value:$120.8M
% of Portfolio:45.4% ($120.8M/$266.1M)
Foghorn Therapeutics Inc.
Shares:1.6M
Value:$5.7M
% of Portfolio:2.2% ($5.7M/$266.1M)
Oric Pharmaceuticals, Inc.
Shares:989.4K
Value:$5.5M
% of Portfolio:2.1% ($5.5M/$266.1M)
PMV Pharmaceuticals, Inc.
Shares:2.6M
Value:$2.9M
% of Portfolio:1.1% ($2.9M/$266.1M)
SPDR S&P 500 ETF TRUST
Shares:4.1K
Value:$2.3M
% of Portfolio:0.9% ($2.3M/$266.1M)
Alector, Inc.
Shares:1.3M
Value:$1.6M
% of Portfolio:0.6% ($1.6M/$266.1M)
Surrozen, Inc./DE
Shares:87.7K
Value:$1.0M
% of Portfolio:0.4% ($1.0M/$266.1M)
RAPT Therapeutics, Inc.
Shares:657.9K
Value:$802.6K
% of Portfolio:0.3% ($802.6K/$266.1M)
Tenaya Therapeutics, Inc.
Shares:1.0M
Value:$579.1K
% of Portfolio:0.2% ($579.1K/$266.1M)
86889P117
Shares:170.8K
Value:$5.1K
% of Portfolio:0.0% ($5.1K/$266.1M)